Passacquale Gabriella, Phinikaridou Alkystis, Warboys Christina, Cooper Margaret, Lavin Begona, Alfieri Alessio, Andia Marcelo E, Botnar Rene M, Ferro Albert
Department of Clinical Pharmacology, BHF Centre of Research Excellence, Cardiovascular Division, King's College London, London, UK.
Division of Imaging Sciences and Biomedical Engineering, BHF Centre of Research Excellence and the Wellcome Trust/EPSRC Medical Engineering Centre, King's College London, London, UK.
Br J Pharmacol. 2015 Jul;172(14):3548-64. doi: 10.1111/bph.13144. Epub 2015 Jun 4.
There are conflicting data regarding whether netrin-1 retards or accelerates atherosclerosis progression, as it can lead either to monocyte repulsion from or retention within plaques depending on its cellular source. We investigated the effect of aspirin, which is widely used in cardiovascular prophylaxis, on the synthesis of different isoforms of netrin-1 by endothelial cells under pro-inflammatory conditions, and defined the net effect of aspirin-dependent systemic modulation of netrin-1 on atherosclerosis progression.
Netrin-1 synthesis was studied in vitro using human endothelial cells stimulated with TNF-α, with or without aspirin treatment. In vivo experiments were conducted in ApoE(-/-) mice fed with a high-fat diet (HFD), receiving either aspirin or clopidogrel.
TNF-α-induced NF-κB activation up-regulated the nuclear isoform of netrin-1, while simultaneously reducing secreted netrin-1. Down-regulation of the secreted isoform compromised the chemorepellent action of the endothelium against monocyte chemotaxis. Aspirin counteracted TNF-α-mediated effects on netrin-1 synthesis by endothelial cells through COX-dependent inhibition of NF-κB and concomitant histone hyperacetylation. Administration of aspirin to ApoE(-/-) mice on HFD increased blood and arterial wall levels of netrin-1 independently of its effects on platelets, accompanied by reduced plaque size and content of monocytes/macrophages, compared with untreated or clopidogrel-treated mice. In vivo blockade of netrin-1 enhanced monocyte plaque infiltration in aspirin-treated ApoE(-/-) mice.
Aspirin counteracts down-regulation of secreted netrin-1 induced by pro-inflammatory stimuli in endothelial cells. The aspirin-dependent increase of netrin-1 in ApoE(-/-) mice exerts anti-atherogenic effects by preventing arterial accumulation of monocytes.
关于网蛋白-1是延缓还是加速动脉粥样硬化进展存在相互矛盾的数据,因为根据其细胞来源,它可导致单核细胞从斑块中排斥或滞留在斑块内。我们研究了广泛用于心血管预防的阿司匹林对促炎条件下内皮细胞中网蛋白-1不同同工型合成的影响,并确定了阿司匹林依赖性全身调节网蛋白-1对动脉粥样硬化进展的净效应。
使用经肿瘤坏死因子-α(TNF-α)刺激的人内皮细胞,在有或无阿司匹林处理的情况下体外研究网蛋白-1的合成。在喂食高脂饮食(HFD)的载脂蛋白E基因敲除(ApoE(-/-))小鼠中进行体内实验,这些小鼠接受阿司匹林或氯吡格雷治疗。
TNF-α诱导的核因子κB(NF-κB)激活上调了网蛋白-1的核同工型,同时减少了分泌型网蛋白-1。分泌型同工型的下调损害了内皮细胞对单核细胞趋化性的化学排斥作用。阿司匹林通过环氧化酶(COX)依赖性抑制NF-κB和伴随的组蛋白高乙酰化,抵消了TNF-α对内皮细胞中网蛋白-1合成的介导作用。与未治疗或氯吡格雷治疗的小鼠相比,给喂食HFD的ApoE(-/-)小鼠施用阿司匹林可独立于其对血小板的作用而增加血液和动脉壁中网蛋白-1的水平,同时斑块大小减小,单核细胞/巨噬细胞含量降低。在体内阻断网蛋白-1可增强阿司匹林治疗的ApoE(-/-)小鼠中的单核细胞斑块浸润。
阿司匹林可抵消促炎刺激诱导的内皮细胞中分泌型网蛋白-1的下调。阿司匹林依赖性增加ApoE(-/-)小鼠中网蛋白-1的水平,通过防止单核细胞在动脉中积聚发挥抗动脉粥样硬化作用。